Facet Biotech News
Most Popular Facet Biotech Story
Abbott buys Facet Biotech for $450M
Abbott has succeeded where Biogen Idec once failed. The company announced late Tuesday that it's purchasing Facet Biotech for $450 million, or $27 a share. That's 67 percent premium over the Read more...
Latest Headlines
- September 14, 2011
- March 9, 2010
- December 17, 2009
- December 16, 2009
- December 4, 2009
- September 21, 2009
- September 8, 2009
- August 31, 2009
- August 28, 2009
- January 7, 2009
- December 22, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
